Medicine Man Technologies hires Bob Finley as Interim CFO at $100K/month

Medicine Man Technologies, Inc.

Bob Finley appointed Interim CFO effective April 21, 2025, via consulting agreement with FLG Partners LLC.
FLG Partners will receive $100,000 per month for Mr. Finley's services for a 12-week term.
Company continues search for a permanent Chief Financial Officer.
Mr. Finley is a CPA and brings 25+ years CFO experience, including in cannabis sector.
Agreement includes indemnification and 30-day termination notice.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Bob Finley

Interim Chief Financial Officer

Medicine Man Technologies, Inc.

Effective: 2025-04-21
Filed: April 21, 2025, 7:59 PM ET

On April 15, 2025, Medicine Man Technologies, Inc. (the “Company”) retained Bob Finley, a partner at FLG Partners, LLC (“FLG Partners”), a chief financial officer services and board advisory consulting firm, as the Company’s Interim Chief Financial Officer (principal financial officer and principal accounting officer).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bob Finley was appointed as Interim Chief Financial Officer at Medicine Man Technologies, Inc..

Action: retained
Role: Interim Chief Financial Officer

Exact text from the filing

On April 15, 2025, Medicine Man Technologies, Inc. (the “Company”) retained Bob Finley, a partner at FLG Partners, LLC (“FLG Partners”), a chief financial officer services and board advisory consulting firm, as the Company’s Interim Chief Financial Officer (principal financial officer and principal accounting officer).

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-25-036825

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.